Form 4: OPKO Health CEO Phillip Frost Acquires 150,000 Shares in Open Market Purchase

OPKO Health's CEO and Chairman, Phillip Frost, acquired 150,000 shares of common stock at a weighted average price of $1.4695 per share on January 17, 2025.

Summary

• Phillip Frost, CEO and Chairman of OPKO Health, acquired 150,000 shares of OPKO common stock on January 17, 2025.
• The shares were purchased at a weighted average price of $1.4695, with individual transaction prices ranging from $1.465 to $1.47.
• Following the transaction, Mr. Frost directly owns 3,568,951 shares and indirectly owns 213,186,477 shares through Frost Gamma Investments Trust and 30,127,177 shares through Frost Nevada Investments Trust.
• Mr. Frost disclaims beneficial ownership of the indirectly held shares, except to the extent of any pecuniary interest.

Sentiment

Score: 6

Explanation: The document reflects a routine insider purchase, which is generally neutral. The CEO's purchase could be seen as a positive signal, but it's not a major event.

Positives

• The CEO's purchase of shares may signal confidence in the company's future prospects.
• The purchase increases the CEO's stake in the company, aligning his interests with those of other shareholders.

Risks

• The document does not indicate any specific risks associated with this transaction.
• The document is a standard SEC Form 4 filing and does not contain any information about the company's overall financial health or future prospects.

Industry Context

This is a routine filing related to insider trading activity and does not provide any specific insights into the broader healthcare industry or OPKO's competitive position.

Comparison to Industry Standards

• Insider trading activity is a common occurrence in publicly traded companies, and this transaction is within the normal range of such activities.
• It is common for CEOs and other executives to purchase shares of their own company, often as a sign of confidence in the company's future.

Stakeholder Impact

• The share purchase may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

OPKO Health, Phillip Frost, insider trading, share purchase, SEC Form 4, common stock, Frost Gamma Investments Trust, Frost Nevada Investments Trust